|
|
Article: FDA Approves New Formulation of Imitrex(R) (Sumatriptan Succinate) Injection.
- Article from:
- PR Newswire
- Article date:
- February 2, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Patients Can Now Take a 4mg Dose Using the Convenient Imitrex STATdose System(R); Imitrex Injection Offers Fast Relief for Migraine, Starts Working As Early As 10 Minutes
RESEARCH TRIANGLE PARK, N.C., Feb. 2 /PRNewswire/ -- The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex Injection that allows a convenient way for patients to take a 4mg dose using the Imitrex STATdose System(R). Imitrex Injection is indicated for the acute treatment of migraines with and without aura in adults.
As many as 28 million Americans suffer from migraine headaches. Migraines can vary from person to person and from attack to attack, ...